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Introduction: Clinical manifestations of Immunoglobulin A Deﬁciency (IgAD) include recur-
rent infections, atopy and autoimmune diseases. However, to our knowledge, the
concomitant evaluations of autoimmune diseases and auto antibodies in a cohort of IgAD
patients with current age >10 years and their relatives have not been assessed.
Objectives: To evaluate autoimmune diseases and the presence of auto antibodies in IgAD
patients and their ﬁrst-degree relatives.
Methods: A cross-sectional study was performed in 34 IgAD patients (current age >10
years) and their ﬁrst-degree relatives. All of them were followed at a tertiary Brazilian
primary immunodeﬁciency center: 27 children/adolescents and 7 of their ﬁrst-degree rela-
tives  with a late diagnosis of IgAD. Autoimmune diseases and autoantibodies (antinuclear
antibodies, rheumatoid factor, and anti-thyroglobulin, anti-thyroperoxidase and IgA class
anti-endomysial antibodies) were also assessed.
Results: Autoimmune diseases (n = 14) and/or autoantibodies (n = 10, four of them with iso-
lated autoantibodies) were observed in 18/34 (53%) of the patients and their relatives. The
most common autoimmune diseases found were thyroiditis (18%), chronic arthritis (12%)
and  celiac disease (6%). The most frequent autoantibodies were antinuclear antibodies
(2%), anti-thyroglobulin and/or anti-thyroperoxidase (24%). No signiﬁcant differences were
observed in the female gender, age at diagnosis and current age in IgAD patients with and
without autoimmune diseases and/or presence of auto antibodies (p > 0.05). The frequen-
cies  of primary immunodeﬁciencies in family, autoimmunity in family, atopy and recurrent
infections were similar in both groups (p > 0.05).
Conclusion: Autoimmune diseases and auto antibodies were observed in IgAD patients dur-
ing  follow-up, reinforcing the necessity of a rigorous and continuous follow-up duringadolescence and adulthood.
© 2014 Elsevier Editora Ltda. All rights reserved.
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Doenc¸as  autoimunes  e  autoanticorpos  em  pacientes  pediátricos  e  seus
parentes  de  primeiro  grau  com  deﬁciência  de  imunoglobulina
Palavras-chave:
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Autoanticorpos
Tireoidite
r  e  s  u  m  o
Introduc¸ão: As manifestac¸ões clínicas da deﬁciência de imunoglobulina A (DIgA) incluem
infecc¸ões  recorrentes, atopia e doenc¸as autoimunes. No entanto, para o nosso conhec-
imento, as avaliac¸ões concomitantes de doenc¸as autoimunes e autoanticorpos em uma
coorte de pacientes com DIgA com idade atual > 10 anos e seus parentes não foram feitas.
Objetivos: Avaliar doenc¸as autoimunes e presenc¸a de autoanticorpos em pacientes com
DIgA  e seus parentes de primeiro grau.
Métodos: Estudo transversal feito em 34 pacientes com DIgA (idade atual > 10 anos) e
em seus parentes de primeiro grau. Todos foram acompanhados em um centro terciário
brasileiro para imunodeﬁciência primária: 27 crianc¸as/adolescentes e sete de seus parentes
de  primeiro grau com diagnóstico tardio de DIgA. Doenc¸as autoimunes e autoanticorpos
(anticorpos antinucleares, fator reumatoide e antitireoglobulina, antitiroperoxidase e anti-
corpos antiendomísio da classe IgA) também foram avaliadas.
Resultados: Doenc¸as autoimunes (n = 14) e/ou autoanticorpos (n = 10, quatro deles com
autoanticorpos isolados) foram observadas em 18/34 (53%) dos pacientes e seus parentes. As
doenc¸as  autoimunes mais comuns encontradas foram tireoidite (18%), artrite crônica (12%)
e  doenc¸a celíaca (6%). Os autoanticorpos mais frequentes foram anticorpos antinucleares
(2%), antitireoglobulina e/ou antitireoperoxidase (24%). Nenhuma diferenc¸a signiﬁcativa foi
observada no sexo feminino, idade no momento do diagnóstico e idade atual em pacientes
com  DIgA com e sem doenc¸as autoimunes e/ou presenc¸a de autoanticorpos (p > 0,05). As
frequências de imunodeﬁciência de primárias na família, autoimunidade em família, atopia
e  infecc¸ões recorrentes foram semelhantes em ambos os grupos (p> 0,05).
Conclusão: Doenc¸as autoimunes e autoanticorpos foram observadas em pacientes com DIgA
durante o acompanhamento, o que reforc¸a a necessidade de um acompanhamento rigoroso
e  contínuo durante a adolescência e a idade adulta.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
IgA deﬁciency (IgAD) is the most frequent primary immuno-
deﬁciency (PID). It is a defect which is caused due to terminal
B lymphocyte differentiation, resulting in an insufﬁcient pro-
duction of serum and secretory IgA (SIgA).1–4 SIgA has some
protective functions on mucosa, neutralizing microorganisms
and proteins.5–8
The clinical manifestations of IgAD patients range from
asymptomatic to recurrent infections, allergic symptoms and
autoimmune diseases,9 with an increased autoantibodies
production.10 Of note, autoimmune diseases occur in 7–36%
of IgAD patients and autoantibodies are observed in more
than 40% of the patients.10,11 The prevalence of IgAD is 1–4%
in systemic lupus erythematosus (SLE) patients,10 2–4% in
rheumatoid arthritis (RA)10 and 2.6% in celiac disease (CD).12
Furthermore, autoimmune diseases are frequently reported in
relatives of IgAD patients. Among the ﬁrst-degree relatives of
IgAD patients, 10% had autoimmune diseases compared to 5%
in general population.11–15
However, to our knowledge, the concomitant evaluation
of autoimmune diseases and auto antibodies in a cohort of
IgAD patients with current age greater than 10 years and their
relatives with IgAD has not been studied.
Therefore, the aim of this study was to evaluate the occur-
rence of autoimmune diseases and auto antibodies in a cohortof IgAD patients with current age greater than 10 years and
their respective ﬁrst-degree relatives followed at a tertiary
Brazilian reference center for pediatric PID.
Patients  and  methods
We selected 126 IgAD patients followed at a Brazilian pedi-
atric reference center for PID in the last 30 consecutive years.
Ninety-two of the IgAD patients who were diagnosed at child-
hood had current age lower than 10 years and were excluded
from this study. IgA assessment was systematically performed
in all ﬁrst-degree relatives that presented any symptoms or
signals of recurrent infectious and autoimmune diseases, and
IgAD diagnosis was established in 7/62 (11%) of ﬁrst-degree
relatives. Therefore, a cross-sectional study was carried out in
34 IgAD patients: 27 IgAD patients (current age greater than 10
years) and their 7 ﬁrst-degree relatives with a late diagnosis of
IgAD. The study was approved by the Ethical Committee and
the written informed consent was obtained from all partici-
pants.
A systematic clinical evaluation was performed and
included the assessments of various autoimmune disor-
ders, recurrent infectious episodes, atopic manifestations
and current or past neoplasia in the IgAD patients and
their respective families. IgAD was diagnosed according to
Pan-American Group for Immunodeﬁciency and European
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Table 1 – Demographic data and clinical features in 34 IgA deﬁciency (IgAD) patients according to the presence of
autoimmune diseases and/or auto-antibodies.
Variables Autoimmune diseases and/or auto antibodies p
With (n = 18) Without (n = 16)
Demographic data
Female 10 (56) 9 (56) 1.0
Age at IgAD diagnosis, yrs 8.9 (4–34) 13.7 (4–52) 0.25
Current age, yrs 19.8 (10–34) 19.6 (10–52) 0.98
Clinical features
PID in family 9 (50) 8 (50) 1.0
Autoimmune diseases in family 2 (11) 3 (19) 0.65
Atopy 11 (61) 11 (69) 0.73
Recurrent infections 15 (83) 16 (100) 0.23
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ociety for Immunodeﬁciency with exclusion of secondary
gAD.16
Juvenile idiopathic arthritis (JIA) was diagnosed accord-
ng to International League of Associations for Rheumatology
ILAR) criteria.17 Childhood-onset SLE (c-SLE) was diagnosed
ccording to American College of Rheumatology criteria.18
nkylosing spondylitis (AS) was deﬁned according to New York
riteria.19 Hypothyroidism was deﬁned as reduced free thy-
oxine (T4) and elevated thyroid stimulating hormone (TSH)
evels. Subclinical hypothyroidism was diagnosed as elevated
SH associated with normal T4. The presence of antithy-
oid antibodies was required to characterize autoimmune
hyroiditis.20 CD was characterized by at least four of the
ollowing ﬁndings: clinical manifestations (chronic diarrhea,
tunting and/or iron deﬁciency anemia), positivity for CD IgA
ntibodies, HLA-DQ2 or DQ8 genotype, small intestine biopsy
ompatible with celiac enteropathy and response to gluten-
ree diet.21
Blood samples were collected from all IgAD patients
nd their relatives. Serum immunoglobulins (IgA, IgM and
gG) were measured by nephelometry (Behring Laser Neph-
lometer, USA) and the results were conﬁrmed if they were
ositive. All patient samples were screened for antinuclear
ntibodies (ANA) by indirect immunoﬂuorescence with HEp-
 cells (Euroimmun AG, Germany). Dilutions ≥1:80 were
eﬁned as positive. Rheumatoid factor (RF) was detected by
mmunonephelometry (Laborclin, Pinhais, Parana, Brazil, and
eference value >8 IU/mL). The serum levels of TSH, free thy-
oxine (free T4), thyroglobulin, anti-thyroglobulin antibodies
anti-TG) and anti-thyroperoxidase antibodies (anti-TPO) were
lso determined. TSH and free T4 were measured by immuno-
etric assays (Auto Delphia, Wallac Oy, Finland). The anti-TG
nd anti-TPO concentrations were determined using ﬂuores-
ence enzymatic immunoassays (Auto Delphia, Wallac Oy,
inland; reference value >35 IU/mL). IgA class anti-endomysial
EMA) antibody of IgA isotype was evaluated by indirect
mmunoﬂuorescence, using the umbilical cord as substrate
Dako, Copenhagen, Denmark; reference value >1:10).tatistical  analysis
esults were presented as mean ± standard deviation or
edian (range) for continuous and number (%) for categoricalciency.
variables. Data were compared by t-test or Mann–Whitney test
for continuous variables. Differences of categorical variables
were assessed by Fisher’s exact test. In all of the statistical
tests, the level of signiﬁcance was set at 5% (p < 0.05).
Results
Autoimmune diseases (n = 14) and/or autoantibodies (n = 10;
four of them with isolated auto antibodies) were observed in
18/34 (53%) of patients and their relatives.
The most common autoimmune disorder was thyroid
autoimmune disease in 6 (18%) of the IgAD subjects:
hypothyroidism (n = 2), subclinical hypothyroidism (n = 2) and
hyperthyroidism (n = 2). Four patients had chronic arthritis:
three patients had JIA (persistent oligoarticular subtype) and
the fourth patient had AS during adulthood. One patient
had isolated haemolytic autoimmune anemia and the other
patient had c-SLE with autoimmune thrombocytopenia. One
patient and his sister had CD with an improvement after
gluten-free diet.
Table 1 includes demographic data and clinical features in
34 IgAD patients and their ﬁrst-degree relatives according to
the presence of autoimmune diseases and/or autoantibodies.
No signiﬁcant differences were observed in the female gen-
der, age at diagnosis and current age in IgAD patients with
and without the presence of autoimmune diseases and/or
of autoantibodies (p > 0.05). Likewise, the frequencies of PID
and the presence of autoimmune diseases in family, atopy
and recurrent infections were similar in both groups (p > 0.05)
(Table 1). Upper respiratory tract infections were the most
common ﬁndings, especially sinusitis (68%) and acute media
otitis (58%).
Autoantibodies were observed in 10/34 (29%) of patients
and their ﬁrst-degree relatives (four of them had autoanti-
bodies without autoimmune diseases). High serum titers of
anti-TG and anti-TPO antibodies were observed in seven and
ﬁve patients, respectively. One ﬁrst-degree relative with CD
had an ANA titer of 1:160 and one patient with c-SLE had an
ANA titer of 1:320. In the patients without clinical autoim-
mune manifestations, two of them had positivity for both
anti-TG and anti-TPO antibodies and the other two patients
had only ANA positivity. Dense ﬁne speckled patterns were
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Table 2 – Demographic data and clinical features in 34 IgA deﬁciency (IgAD) patients according to presence of
autoantibodies.
Variables Autoantibodies p
With  (n = 10) Without (n = 24)
Demographic data
Female 7 (70) 12 (50) 0.45
Age at IgAD diagnosis, yrs 8.6 (4–30) 12.2 (4–52) 0.42
Current age, yrs 17.4 (12–30) 20.8 (10–52) 0.35
Clinical features
PID in family 5 (50) 12 (50) 1.0
Autoimmune diseases in family 2 (20) 3 (13) 0.62
Atopy 6 (60) 16 (67) 0.71
Recurrent infections 9 (90) 22 (92) 1.0
odeﬁResults are presented in n (%) or median (range); PID, primary immun
observed in ANA-HEp-2 cells of all patients. RF was absence in
all IgAD subjects.
Demographic data and clinical features in 34 IgAD patients
according to the presence of auto antibodies are shown in
Table 2. Female gender, age at diagnosis and current age were
similar in IgAD patients with and without the presence of auto
antibodies (p > 0.05). PID and autoimmune diseases in family,
atopy and recurrent infections were also comparable in both
groups (p > 0.05, Table 2).
Discussion
Antibody deﬁciencies are the most common PID in our Univer-
sity Hospital, particularly IgAD.22,23 The present study showed
a high prevalence of autoimmune diseases and autoantibodies
in IgAD patients followed-up at a tertiary teaching center.
Of note, various clinical manifestations may occur in IgAD
patients, ranging from asymptomatic to recurrent infections,
allergic symptoms and autoimmune diseases. The clinical
spectrum probably depends on the association with anti-
body deﬁciencies, such as IgG2 subclass deﬁciency, speciﬁc
antibody deﬁciency, mannose-binding lectin deﬁciency or
common variable immunodeﬁciency.24 Other possible patho-
genesis is a compensatory mechanism, such as high salivary
IgM and IgG.25 In the present study, none of the IgAD patients
had any other PID.
Autoimmune diseases occur more  frequently in IgAD
patients compared to healthy populations,12,22 with the pos-
sibility of autoantibodies production, even without autoim-
mune clinical manifestations,10,13 as observed herein. Both
systemic and organ-speciﬁc autoimmune diseases have been
described in association with IgAD13 and the main autoim-
mune disorders associated with this immunodeﬁciency were:
hypothyroidism, CD and rheumatic diseases.9–13,26 Recently,
IgAD has also been evidenced in 4% of our c-SLE population.27
Additionally, hematologic autoimmune disorders are very
frequent in PID patients, especially antibody deﬁciencies, such
as common variable immunodeﬁciency and IgAD, particu-
larly idiopathic thrombocytopenic purpura and autoimmune
haemolytic anemia, as evidenced in two of our IgAD
patients.28ciency.
Importantly, the diagnosis of CD in IgAD patients may be
very difﬁcult, since the majority of the tests are based on spe-
ciﬁc IgA antibody. Therefore, it is important to measure the
total serum IgA levels before the CD diagnosis.29
Regarding pathogenesis of autoimmunity in IgAD patients,
the absence of IgA on mucosal surfaces induces absorption
of many  environmental antigens, such as diet proteins, and
may provoke cross-reaction with self-antigens.30,31 Moreover,
the inability of defective immune response to handle these
antigens may result in a compensatory response, thus leading
to tissue damage and autoimmunity.32,33 In addition, speciﬁc
haplotypes (HLA-A1, HLA-B8 and HLA-DR3) were also found
in IgAD patients associated with autoimmune diseases.33
Isolated ANA was also observed in our asymptomatic
patients. Indeed, a Brazilian study showed that 12.6% of
healthy children and adolescents in São Paulo had a positive
ANA titer >1/80, without the presence of other autoantibodies.
However, in this study IgA levels were not assessed.34
Auto antibodies were observed in 29% of our IgAD
patients. This frequency was higher than our pediatric lep-
rosy patients (16%)35 and was lower than our c-SLE, juvenile
dermatomyositis36 and RASopathies37 patients, who  pre-
sented up to 93%, 59% and 52% of auto antibodies, respectively.
Another relevant result of the present study was the
identiﬁcation of IgAD in ﬁrst-degree relatives, most of them
asymptomatic, reinforcing the importance of PID evaluation
in family members. Although many  relatives had autoim-
mune diseases and mild infections, these manifestations were
neglected by them and by physicians. Therefore, autoimmune
diseases and infectious manifestations should be considered
in the relatives with IgAD.
This study has limitations. These patients were referred
to a tertiary university hospital, some of them with more
complex diseases, which may have overestimated the autoim-
mune disorders in this group. Additionally, infants and
children lower than 10 years, which is the most prevalent age
group for this kind of PID, were excluded. A healthy control
group was also not assessed.
In conclusion, a high prevalence of autoimmune diseases
and autoantibodies was observed in IgAD patients, reinforcing
the rigorous and continuous follow-up during adolescence
and adulthood.
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